News

Published on 13 Sep 2023 on Zacks via Yahoo Finance

Stryker (SYK) Gets FDA 501k Clearance for Pangea Trauma Systems


Article preview image

Stryker SYK announced that it has gained 510k clearance from the FDA for its Pangea systems, including Femur, Fibula, Tibia, Humerus and Utility.

The FDA clearance for Pangea systems will boost Stryker’s comprehensive portfolio of devices for a wide range of trauma needs.

The Pangea systems is an intuitive and streamlined instrumentation and implant tray that includes 20 anatomic plates and 13 utility plates accessible under one platform. The systems has been designed collaboratively by world-renowned orthopaedic surgeons who offered an evidence-based design for implant fit. It will offer solutions that will enhance plate fit and screw placement. The systems will also include anatomically contoured implants in patient populations with a wide variety of fracture patterns.

NYSE.SYK price evolution
NYSE.MCK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Why Is Larry Robbins Bullish on McKesson Corporation (MCK) Now?

We recently compiled a list of the Billionaire Larry Robbins’ Long-Term Stock Picks. In this...

Insider Monkey · via Yahoo Finance 24 Jan 2025

McKesson Corporation (NYSE:MCK) is favoured by institutional owners who hold 89%...

Key Insights Institutions' substantial holdings in McKesson implies that they have significant...

Simply Wall St. · via Yahoo Finance 22 Jan 2025

MEANWHILE AT THE SUPREME COURT: Justices Seem Leery of Striking Down Hobbs Act...

Except that the Hobbs Act is currently under attack at the US Supreme Court in a case called...

The National Law Review 22 Jan 2025

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

McKesson (MCK) San Francisco, CA-based McKesson Corporation is a health care services and...

Zacks · via Yahoo Finance 22 Jan 2025

McKesson Stock Declines Post Divestiture of Canada-Based Businesses

A few other top-ranked stocks in the broader medical space are Cardinal Health, Inc. CAH, ResMed...

Zacks · via Yahoo Finance 2 Jan 2025

Jim Cramer’s Take on McKesson Corporation (MCK): Bold Predictions for the Future

We recently compiled a list of the Jim Cramer’s Bold Predictions About These 10 Healthcare Stocks...

Insider Monkey · via Yahoo Finance 1 Jan 2025

Investing in McKesson (NYSE:MCK) five years ago would have delivered you a 333%...

Buying shares in the best businesses can build meaningful wealth for you and your family. And we'...

Simply Wall St. · via Yahoo Finance 30 Dec 2024

5 Beaten-Down MedTech Stocks Set to Rebound in 2025

In October, it launched InspiroGene, a dedicated business within the U.S. Pharmaceutical segment ...

Zacks · via Yahoo Finance 30 Dec 2024

Why McKesson (MCK) is a Top Value Stock for the Long-Term

/E, PEG, Price/Sales, and Price/Cash Flow to highlight the most attractive and discounted stocks....

Zacks · via Yahoo Finance 30 Dec 2024

Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to...

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it i...

Zacks · via Yahoo Finance 25 Dec 2024